Listen on the go
CORRECT!
Next question
touchOPHTHALMOLOGY touchOPHTHALMOLOGY
Refractive Surgery
Watch Time: 06:43 mins

Gregory Parkhurst, AAO 2022: Advice for transitioning to implantable collamer lens

Share this Video
Copy Link
Published Online: Oct 20th 2022

In this touchOPHTHALMOLOGY interview about his AAO 2022 presentation, Dr Gregory Parkhurst (Parkhurst NuVision, San Antonio, TX, US) talked to about the best practices for helping patients when they considering implantable collamer lens and provides some insightful suggestion to consulting physicians. 

‘I Can’t Have LASIK … Now What?  Transitioning to ICL surgery’ was presented at the annual American Academy of Ophthalmology (AAO) meeting, 30 September – 3 October 2022 

  1. What should be discussed in an initial consultation with a patient when considering implantable collamer lens? (00:18)
  2. What resources can be used for patient communication and education? (02:39)
  3. What other advice would you give to consulting physicians? (04:49)

Disclosure: Dr Gregory Parkhurst is a consultant for and receives grant/research support from Staar Surgical

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed as a highlight of AAO 2022.

Related Videos In Refractive Surgery
Cataract Surgery, Refractive Surgery
Developed by Touch
Mitchell A Jackson, Hawaiian Eye and Retina 2023: Intraocular lens exchange – surgical pearls
Watch Time: 7:07 mins

It was a pleasure to have the opportunity to meet with Dr Mitchell A Jackson (Jacksoneye, Lake Villa, IL, USA)  who shared surgical pearls from his presentation, on successful IOL exchange with an open capsule. Questions:     What risks are associated with intraocular lens (IOL) exchange with an open capsule? (0:19)     What […]

Cataract Surgery, Refractive Surgery
Developed by Touch
Mitchell A Jackson, Hawaiian Eye and Retina 2023: Challenges for ophthalmic surgeons
Watch Time: 3:45 mins

We were delighted to speak with Dr Mitchell A Jackson (Jacksoneye, Lake Villa, IL, USA) on his views about the main challenges faced by ophthalmic surgeons today, and common reasons for IOL exchange. Questions: 1. What are the biggest challenges facing ophthalmologic surgeons today? (0:19) 2. What are the most common reasons for intraocular lens […]

Refractive Surgery
Pilocarpine hydrochloride ophthalmic solution 1.25%: An innovative prescription eye drop for the treatment of presbyopia
Watch Time: 5:02

Video abstract delivered by Dr Selina McGee (BeSpoke Vision, Edmond, OK, USA) for the article: McGee S, Waring GO, Pilocarpine hydrochloride ophthalmic solution 1.25%: an innovative prescription eye drop for the treatment of presbyopia. touchREVIEWS in Ophthalmology. 2022;16(2):54–62 DOI: https://doi.org/10.17925

Trending In Refractive Surgery:

Mitchell A Jackson, Hawaiian Eye and Retina 2023: Intraocular lens exchange – surgical pearls
Cataract Surgery, Refractive Surgery
    • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72